Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-29

FDA Approved: FINGOLIMOD — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for fingolimod from XLCare Pharmaceuticals Inc., indicating regulatory approval of a supplemental submission for this pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)